About
NeuVasQ develops first-in-class pharmaceuticals targeting blood-brain barrier dysfunction to treat neurological conditions such as stroke, glioblastoma, and neurodegenerative disorders by restoring barrier integrity.
Explore NeuVasQ's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.